Why GE HealthCare Technologies Inc.’s (GEHC) Stock Is Down 9.99%

By Rosalio Madrigal
May 21, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate GE HealthCare Technologies Inc. before investing.

In this article, we go over a few key elements for understanding GE HealthCare Technologies Inc.’s stock price such as:

  • GE HealthCare Technologies Inc.’s current stock price and volume
  • Why GE HealthCare Technologies Inc.’s stock price changed recently
  • Upgrades and downgrades for GEHC from analysts
  • GEHC’s stock price momentum as measured by its relative strength

About GE HealthCare Technologies Inc. (GEHC)

Before we jump into GE HealthCare Technologies Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women’s health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women’s health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Want to learn more about GE HealthCare Technologies Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about GE HealthCare Technologies Inc..

Learn More About A+ Investor

GE HealthCare Technologies Inc.’s Stock Price as of Market Close

As of May 21, 2026, 4:00 PM, CST, GE HealthCare Technologies Inc.’s stock price was $64.330.

GE HealthCare Technologies Inc. is up 0.11% from its previous closing price of $64.260.

During the last market session, GE HealthCare Technologies Inc.’s stock traded between $62.730 and $65.000. Currently, there are approximately 456.00 million shares outstanding for GE HealthCare Technologies Inc..

GE HealthCare Technologies Inc.’s price-earnings (P/E) ratio is currently at 15.4, which is low compared to the Health Care Equipment & Supplies industry median of 25.4. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

GE HealthCare Technologies Inc. Stock Price History

GE HealthCare Technologies Inc.’s (GEHC) price is currently up 5.74% so far this month.

During the month of May, GE HealthCare Technologies Inc.’s stock price has reached a high of $65.000 and a low of $59.810.

Over the last year, GE HealthCare Technologies Inc. has hit prices as high as $89.770 and as low as $58.750. Year to date, GE HealthCare Technologies Inc.’s stock is down 21.57%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused GE HealthCare Technologies Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 21, 2026, there were 0 analysts who downgraded GE HealthCare Technologies Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate GE HealthCare Technologies Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on GE HealthCare Technologies Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

GE HealthCare Technologies Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about GE HealthCare Technologies Inc. (GEHC) by visiting AAII Stock Evaluator.

Relative Price Strength of GE HealthCare Technologies Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 21, 2026, GE HealthCare Technologies Inc. has a weighted four-quarter relative price strength of -11.00%, which translates to a Momentum Score of 24 and is considered to be Weak.

Want to learn more about how GE HealthCare Technologies Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

GE HealthCare Technologies Inc. Stock Price: Bottom Line

As of May 21, 2026, GE HealthCare Technologies Inc.’s stock price is $64.330, which is up 0.11% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like GE HealthCare Technologies Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Shaughnessy Tiny Titans
Screen:
23.7%
Annual Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.